2010
DOI: 10.1038/gt.2010.14
|View full text |Cite
|
Sign up to set email alerts
|

A dual promoter lentiviral vector for the in vivo evaluation of gene therapeutic approaches to axon regeneration after spinal cord injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
15
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(15 citation statements)
references
References 65 publications
0
15
0
Order By: Relevance
“…This plasmid was modified by replacing the CMV promoter with the CAG composite promoter (human cytomegalovirus immediate-early enhancer with a modified chicken beta-actin promoter and beta globin intron) for the expression of EGFP (Niwa et al, 1991). The EGFP cDNA in this plasmid can be exchanged for any other transgene of interest using the Gateway (Invitrogen) recombination system (Low et al, 2010). Expression of a second reporter gene, copGFP, is driven by the EF-1α promoter.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…This plasmid was modified by replacing the CMV promoter with the CAG composite promoter (human cytomegalovirus immediate-early enhancer with a modified chicken beta-actin promoter and beta globin intron) for the expression of EGFP (Niwa et al, 1991). The EGFP cDNA in this plasmid can be exchanged for any other transgene of interest using the Gateway (Invitrogen) recombination system (Low et al, 2010). Expression of a second reporter gene, copGFP, is driven by the EF-1α promoter.…”
Section: Methodsmentioning
confidence: 99%
“…The total size of this plasmid is approximately 10 kb. The combination of CAG and EF-1α promoters has previously been shown to allow for the simultaneous, long-term expression of two transgenes in adult CNS neurons after lentiviral vector delivery (Low et al, 2010). A lentiviral plasmid was used to allow for the rapid transition from in vitro electroporation to in vivo viral gene transfer.…”
Section: Methodsmentioning
confidence: 99%
“…In this way, although individual cells will still receive varying levels of TFs, the ratio of the two will be much more consistent. Alternatively, a dual promoter design in which each TF is under the control of a different promoter, could enable skewed ratios by selecting promoters with differing levels of activity in the cell type of interest [48]. In addition, when the optimal ratio is unknown, it should also be possible to take advantage of inducible promoters to systematically vary the production of exogenously expressed TFs.…”
Section: Physical Interactionmentioning
confidence: 99%
“…GFP, GFP-SnoN, or GFP-SnoN-D-box mutation plasmids were expressed by a hybrid chick beta actin – minimal CMV (CAG) promoter, and the reporter gene copGFP was driven by an EF1-α promoter, as previously described [11]. To facilitate histological detection of SnoN, we fused the GFP reporter to the amino terminal of SnoN; the resulting fusion protein was functional, as shown in Results.…”
Section: Methodsmentioning
confidence: 99%